PEAK6 Group’s Juno Therapeutics, Inc. JUNO Stock Holding History

PEAK6 Group’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,500	Closed	-$69K	–	5333
2017 Q4	$69K	Hold	1,500	–	–	﹤0.01%	3673
2017 Q3	$67K	Hold	1,500	–	–	﹤0.01%	3921
2017 Q2	$45K	Hold	1,500	–	–	﹤0.01%	4140
2017 Q1	$33K	Sell	1,500 -16,700	-92%	-$358K	﹤0.01%	3958
2016 Q4	$343K	Sell	18,200 -3,500	-16%	-$85.6K	﹤0.01%	2864
2016 Q3	$651K	Sell	21,700 -98,100	-82%	-$3.05M	﹤0.01%	2129
2016 Q2	$4.61M	Buy	119,800 +45,600	+61%	+$1.89M	0.04%	719
2016 Q1	$2.83M	Buy	+74,200	New	+$2.59M	0.02%	951
2015 Q4	–	Sell	-24,000	Closed	-$977K	–	5662
2015 Q3	$977K	Buy	+24,000	New	+$1.05M	0.01%	2214
2015 Q2	–	Sell	-17,000	Closed	-$1.03M	–	5770
2015 Q1	$1.03M	Buy	+17,000	New	+$825K	0.01%	1860

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

PEAK6 Group's JUNO Position: Q1 2018 in Review

PEAK6 Group sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 2,716 shares — an estimated $124K sold.

PEAK6 Group first reported a position in JUNO in Q1 2016 and held it in 7 quarters. The position peaked at $1.04M in Q1 2016. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

PEAK6 Group reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
PEAK6 Group sold 2,716 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $124K.
PEAK6 Group first reported a position in Juno Therapeutics, Inc. in Q1 2016 and held it in 7 quarters.
PEAK6 Group's Juno Therapeutics, Inc. position peaked at $1.04M in Q1 2016.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.